Cassava sciences, inc. being investigated on behalf of cassava sciences, inc. investors. contact levi & korsinsky for details

New york, ny / accesswire / november 29, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of cassava sciences, inc. ("cassava sciences, inc.") (nasdaq:sava) concerning possible violations of federal securities laws. on november 25, 2024, cassava "today announced that the topline results from the phase 3 rethink-alz study of simufilam in mild-to-moderate ad [alzheimer's disease] did not meet each of the pre-specified co-primary, secondary and exploratory biomarker endpoints.
sava Ratings Summary
sava Quant Ranking